The Safety and Tolerability of A8G6 COVID-19 Neutralization Antibody Combined With Nasal Spray

Conditions: SARS-CoV-2; Prevention Interventions: Biological: A8G6 SARS-CoV-2 Neutralization Antibody combination nasal spray; Other: A8G6 SARS-CoV-2 Neutralization Antibody nasal excipient Sponsors: The Second Affiliated Hospital of Chongqing Medical University Recruiting

Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials